S&P 500   4,145.19
DOW   32,803.47
QQQ   324.34
What to Expect from the Markets in a Recession
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
China July exports rise, with trade surplus at record-high
Electric Vehicles Can Drive Alcoa Stock Higher
What's in Democrats' big bill? Climate, health care, savings
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Bangladesh seeks China help to repatriate Rohingya refugees
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   324.34
What to Expect from the Markets in a Recession
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
China July exports rise, with trade surplus at record-high
Electric Vehicles Can Drive Alcoa Stock Higher
What's in Democrats' big bill? Climate, health care, savings
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Bangladesh seeks China help to repatriate Rohingya refugees
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   324.34
What to Expect from the Markets in a Recession
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
China July exports rise, with trade surplus at record-high
Electric Vehicles Can Drive Alcoa Stock Higher
What's in Democrats' big bill? Climate, health care, savings
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Bangladesh seeks China help to repatriate Rohingya refugees
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
S&P 500   4,145.19
DOW   32,803.47
QQQ   324.34
What to Expect from the Markets in a Recession
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
China July exports rise, with trade surplus at record-high
Electric Vehicles Can Drive Alcoa Stock Higher
What's in Democrats' big bill? Climate, health care, savings
Tailor an Options Trading Strategy to Fit Your Needs (Ad)pixel
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Bangladesh seeks China help to repatriate Rohingya refugees
27 U.S. Cities Where Stocks Yield 26% a Year (Ad)pixel
NYSE:CC

Chemours - CC Stock Forecast, Price & News

$34.49
0.00 (0.00%)
(As of 08/8/2022 07:36 AM ET)
Add
Compare
Today's Range
$34.40
$35.20
50-Day Range
$29.39
$44.79
52-Week Range
$22.56
$44.95
Volume
37,786 shs
Average Volume
1.76 million shs
Market Capitalization
$5.35 billion
P/E Ratio
6.43
Dividend Yield
2.90%
Price Target
$40.17

Chemours MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
16.5% Upside
$40.17 Price Target
Short Interest
Healthy
3.16% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.39mentions of Chemours in the last 14 days
Based on 15 Articles This Week
Insider Trading
Selling Shares
$1.77 M Sold Last Quarter
Proj. Earnings Growth
8.50%
From $5.53 to $6.00 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.76 out of 5 stars

Basic Materials Sector

23rd out of 225 stocks

Chemicals & Allied Products Industry

3rd out of 17 stocks

CC stock logo

About Chemours (NYSE:CC) Stock

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

Chemours Stock Performance

Shares of CC opened at $34.49 on Monday. The company has a market cap of $5.35 billion, a PE ratio of 6.43, a price-to-earnings-growth ratio of 0.43 and a beta of 1.82. The company has a current ratio of 1.91, a quick ratio of 1.27 and a debt-to-equity ratio of 3.01. The stock has a 50-day moving average price of $34.93 and a 200-day moving average price of $33.69. Chemours has a 12-month low of $22.56 and a 12-month high of $44.95.

Chemours (NYSE:CC - Get Rating) last announced its quarterly earnings data on Thursday, July 28th. The specialty chemicals company reported $1.89 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.47. The company had revenue of $1.92 billion for the quarter, compared to analysts' expectations of $1.84 billion. Chemours had a return on equity of 79.77% and a net margin of 12.72%. Chemours's revenue for the quarter was up 15.7% compared to the same quarter last year. During the same period last year, the firm posted $1.20 EPS. As a group, equities analysts forecast that Chemours will post 5.53 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 15th. Investors of record on Monday, August 15th will be issued a dividend of $0.25 per share. The ex-dividend date is Friday, August 12th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.90%. Chemours's dividend payout ratio is 18.66%.

Analyst Ratings Changes

Several research analysts have commented on the company. Citigroup raised their target price on Chemours from $32.00 to $36.00 in a research note on Wednesday, August 3rd. Barclays raised their target price on Chemours from $37.00 to $46.00 in a research note on Monday, May 9th. Bank of America downgraded Chemours from a "buy" rating to a "neutral" rating and cut their target price for the stock from $48.00 to $44.00 in a research note on Tuesday, June 14th. Royal Bank of Canada raised their target price on Chemours from $44.00 to $48.00 and gave the stock an "outperform" rating in a research note on Monday, August 1st. Finally, UBS Group raised their target price on Chemours from $35.00 to $37.00 and gave the stock a "neutral" rating in a research note on Friday, July 29th. Three analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $40.17.

Insider Activity at Chemours

In related news, insider Edwin C. Sparks sold 22,142 shares of the firm's stock in a transaction dated Tuesday, June 7th. The stock was sold at an average price of $43.59, for a total transaction of $965,169.78. Following the transaction, the insider now directly owns 101,038 shares of the company's stock, valued at approximately $4,404,246.42. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 3.04% of the stock is currently owned by insiders.

Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Stock News Headlines

Citigroup Boosts Chemours (NYSE:CC) Price Target to $36.00
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
Chemours (NYSE:CC) PT Raised to $48.00 at Royal Bank of Canada
Chemours (NYSE:CC) Rating Reiterated by Royal Bank of Canada
CC vs. ALB: Which Stock Is the Better Value Option?
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
Chemours (NYSE:CC) Lifted to "Strong-Buy" at StockNews.com
Chemours (NYSE:CC) Is Paying Out A Dividend Of $0.25
Chemours (NYSE:CC) PT Raised to $37.00
Recap: Chemours Q2 Earnings - Benzinga
Chemours (CC) to Release Quarterly Earnings on Thursday
See More Headlines
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

CC Company Calendar

Ex-Dividend for 6/15 Dividend
5/13/2022
Dividend Payable
6/15/2022
Last Earnings
7/28/2022
Today
8/08/2022
Ex-Dividend for 9/15 Dividend
8/12/2022
Dividend Payable
9/15/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Fax
N/A
Employees
6,400
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$40.17
High Stock Price Forecast
$48.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+16.5%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$608 million
Pretax Margin
15.03%

Debt

Sales & Book Value

Annual Sales
$6.35 billion
Cash Flow
$6.14 per share
Book Value
$6.64 per share

Miscellaneous

Free Float
150,422,000
Market Cap
$5.35 billion
Optionable
Optionable
Beta
1.82














CC Stock - Frequently Asked Questions

Should I buy or sell Chemours stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Chemours stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View analyst ratings for Chemours
or view top-rated stocks.

What is Chemours' stock price forecast for 2022?

4 Wall Street research analysts have issued twelve-month target prices for Chemours' stock. Their CC stock forecasts range from $30.00 to $48.00. On average, they anticipate Chemours' share price to reach $40.17 in the next twelve months. This suggests a possible upside of 16.5% from the stock's current price.
View analysts' price targets for Chemours
or view top-rated stocks among Wall Street analysts.

How has Chemours' stock price performed in 2022?

Chemours' stock was trading at $33.56 at the start of the year. Since then, CC shares have increased by 2.8% and is now trading at $34.49.
View the best growth stocks for 2022 here
.

When is Chemours' next earnings date?

Chemours is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our earnings forecast for Chemours
.

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) issued its quarterly earnings data on Thursday, July, 28th. The specialty chemicals company reported $1.89 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.42 by $0.47. The specialty chemicals company earned $1.92 billion during the quarter, compared to analyst estimates of $1.84 billion. Chemours had a net margin of 12.72% and a trailing twelve-month return on equity of 79.77%. Chemours's revenue was up 15.7% on a year-over-year basis. During the same period in the prior year, the firm posted $1.20 earnings per share.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Thursday, July 28th. Stockholders of record on Monday, August 15th will be paid a dividend of $0.25 per share on Thursday, September 15th. This represents a $1.00 annualized dividend and a yield of 2.90%. The ex-dividend date of this dividend is Friday, August 12th.
View Chemours' dividend history
.

Is Chemours a good dividend stock?

Chemours(NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 2.90%. The dividend payout ratio of Chemours is 18.66%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Chemours will have a dividend payout ratio of 16.67% next year. This indicates that Chemours will be able to sustain or increase its dividend.
View Chemours' dividend history.

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours CEO Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among Chemours' employees.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

What is Chemours' stock symbol?

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Who are Chemours' major shareholders?

Chemours' stock is owned by many different retail and institutional investors. Top institutional shareholders include Vaughan Nelson Investment Management L.P. (0.71%), Private Management Group Inc. (0.56%), M&T Bank Corp (0.38%), Retirement Systems of Alabama (0.33%), Los Angeles Capital Management LLC (0.30%) and Janney Montgomery Scott LLC (0.16%). Company insiders that own Chemours stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, E Bryan Snell, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott, Richard H Brown and Sameer Ralhan.
View institutional ownership trends for Chemours
.

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $34.49.

How much money does Chemours make?

Chemours (NYSE:CC) has a market capitalization of $5.35 billion and generates $6.35 billion in revenue each year. The specialty chemicals company earns $608 million in net income (profit) each year or $5.36 on an earnings per share basis.

How many employees does Chemours have?

Chemours employs 6,400 workers across the globe.

How can I contact Chemours?

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The official website for Chemours is www.chemours.com. The specialty chemicals company can be reached via phone at (302) 773-1000 or via email at investor@chemours.com.

This page (NYSE:CC) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.